References
- Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, Lesosky M, et al. Feasibility, accuracy and clinical effects of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet. 2014;383:424–35.
- Churchyard G, McCarthy K, Fielding KL, Stevens W, Chihota V, Nicol M, et al. Effect of Xpert MTB/RIF on early mortality in adults with suspected TB: a pragmatic randomized trial. In: Proceedings of the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014); 3–6 March 2014; Boston, MA, USA. Abstract 95.
- WHO. Implementation and roll-out of Xpert MTB/RIF May 2013. Update from the STOP TB Department. Geneva: World Health Organization; 2013.